Physician profile
Deepak Pottayil Thomas
NPI 1457535551
$5,089.91
in general payments reported to CMS, 2019-2025
14 companies · $691 in 2025
The $691 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $494 · 2021: $358 · 2022: $885 · 2023: $938 · 2024: $1,114 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,742.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,396.72 | 2019-2025 | Dragonfly Opstar, Ultreon, Cardiomems |
| Shockwave Medical, INC | $1,086.85 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $1,055.99 | 2019-2025 | Impella |
| Asahi Intecc USA, INC. | $324.13 | 2020-2022 | |
| Medtronic, INC. | $275.67 | 2024-2025 | Symplicity G3 |
| Cardiovascular Systems INC. | $253.85 | 2020-2022 | |
| Penumbra, INC. | $147.93 | 2022 | |
| Medtronic Vascular, INC. | $112.07 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $100.87 | 2019 | |
| Boston Scientific Corporation | $98.50 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $94.64 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $94.25 | 2019 | |
| Edwards Lifesciences Corporation | $31.95 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Terumo Medical Corporation | $16.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepak Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.